How often does Aquestive Therapeutics move more than the options market prices?

2 of the last 8 reports moved at least as far as the implied move.

AQSTNasdaqPharmaceutical Preparations

Aquestive Therapeutics, Inc. (AQST) earnings date, market-implied expected move, and options open interest by expiry

3.89

+0.12 · +3.16%

post 3.79 −2.55%

Closed17:28 ET

Open3.80Volume2.1MMkt cap$487.7MEPS-0.64

Day3.79 – 3.910%52-wk2.93 – 6.8522%

AQST

Aquestive Therapeutics, Inc.

OpenVolumeMkt capP/EEPSDiv yield

Day – 52-wk –

Expected move

No implied move.

Expected move

Inputs

Next report

Mar 8

after close · in 125 days

est.Q4 FY26

Calendar

Next report

Last report

Nov 3

after close

confirmedQ3 FY26Nov 2 close

Implied vs realized

Largest filed tie

73.00%

of AQST revenue · Indivior

customerAQST 10-K

Supply chain

Largest filed tie

13F top-10 QoQ

+0.68%

shares held · 10 largest managers

13F · Jun 30 '26127d lag

186 managers

Top fund weight

0.01%

AQST weight · IWM

N-PORTJun 30 '26

3 funds

Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied

Aquestive Therapeutics (AQST) is expected to report on Mar 8 after close (estimated date).

Implied vs realized

8 reports

2 of 8≥ implied

avg implied: ±17.3%
avg realized: ±6.7%

Jan 13 '25Jan 13 '25confirmed±17.6%▲+0.97%×0.06

Mar 5 '25Mar 5 '25confirmed±23.2%▼−7.53%×0.32

May 12 '25May 12 '25confirmed±14.9%▼−19.65%×1.32

Aug 11 '25Aug 11 '25confirmed±32.2%▼−2.07%×0.06

Q3 FY25Nov 5 '25confirmed±16.2%▲+2.17%×0.13

Q1 FY26Mar 4 '26confirmed±14.1%▼−2.52%×0.18

May 13 '26May 13 '26confirmed±7.7%▲+14.53%×1.88

Q2 FY26Aug 11 '26confirmed±12.4%▼−4.08%×0.33

quarterimplied−35%0+35%realized×

Q2 FY26±12.4%▼−4.08%×0.33

May '26±7.7%▲+14.53%×1.88

Q1 FY26±14.1%▼−2.52%×0.18

Q3 FY25±16.2%▲+2.17%×0.13

Aug '25±32.2%▼−2.07%×0.06

May '25±14.9%▼−19.65%×1.32

2 older reports

Mar '25±23.2%▼−7.53%×0.32

Jan '25±17.6%▲+0.97%×0.06

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Implied vs realized

Positioning

OI · 3 expiries · Oct 30 close

1.03OI · 3 expiries · Oct 30 closeP/C open interest · Nov 20 · nearest expiry

PUTS · chgexpiry · days · P/CCALLS · chgP/C

22,6440%Nov 2017d21,940+1%

16,5270%Dec 1845d44.43372+30%44.43

5,3500%Feb 19108d0.559,691−1%0.55

ExpiryPutsCallsP/C

Nov 2017d22,6440%21,940+1%1.03

Dec 1845d16,5270%372+30%44.43

Feb 19108d5,3500%9,691−1%0.55

Hatched = puts · solid = calls · bars scaled per expiry · chg = OI vs prior sessionSource: options EOD

Positioning

Linked exposure

No implied move.

Linked exposure

Revenue flow

as filedQ3 FY26

−218.29%as filednet margin · revenue −45.31% QoQ · −40.99% YoY

Revenue$8M−45.31%

Gross profit$4M52.28%−59.69%

Operating income−$14M−191.46%−75.96%

Pre-tax income−$16M+27.85%

Net income−$16M−218.29%+27.85%

Cost of revenue$4M−10.23%

Operating expenses$18M+2.19%

Other expense−$2M+86.16%

Source: SEC filings · standardized · QE Sep 30 '26 · bars = % of revenue

Revenue flow

Intraday

15m bars

Hatch = extended hours · ▯ up · ▮ downSource: market data · 17:15 ET

Intraday

Event sensitivity

NFP ×1.53· ±5.2% vs ±3.4% · 10 releases

eventrelease day|move|up · n×base

NFPjobs report±5.2%3 of 10×1.53

PCEpersonal income & outlays±3.2%7 of 19×0.94

FOMCrate decision±3.1%12 of 24×0.92

PPIproducer prices±2.7%3 of 10×0.80

CPROFcorporate profits±2.6%4 of 12×0.77

CPIconsumer prices±2.5%2 of 10×0.73

GDPgross domestic product±2.2%7 of 19×0.64

Bar = avg |move| to ±6% · tick = ±3.4% avg day · ×base = |move| ÷ ±3.4% · min 6 releases

Earnings history

EPS -0.13 · consensus —

Quarter	Reported	EPS	Consensus
Q3 FY26	—	-0.13	—
Q2 FY26	Aug 11 '26 · confirmed	-0.18	—
Q1 FY26	Mar 4 '26 · confirmed	-0.07	—
Q3 FY25	Nov 5 '25 · confirmed	-0.14	—

Source: filed financials

Methodology

ties · implied moves · holdersMethod